Why people use CJC-1295 for growth hormone support
You're 40+, growth hormone is dropping. CJC-1295 to bring it back? The honest answer: yes, there is real clinical evidence here, not just gym-bro consensus. CJC-1295 is a long-acting GHRH (growth-hormone-releasing hormone) analog - it tells your pituitary gland to make more of its own growth hormone.
This page covers what's known, what's not, and what the editorial take is for normal humans considering CJC-1295 for growth hormone support.
What the evidence says
Evidence tier: Strong clinical. Multiple human studies support the dosing protocol; not yet FDA-labeled for this exact indication but close.
- CJC-1295 is a long-acting GHRH (growth-hormone-releasing hormone) analog - it tells your pituitary gland to make more of its own growth hormone.
- Phase 1 and 2 trials (Teichman et al., 2006) showed sustained 2-10x increases in growth hormone over a week.
- Most-prescribed peptide pair in US compounding for body composition - usually stacked with Ipamorelin.
Protocol notes
100mcg subcutaneous before bed, 5 days per week. Most often stacked with Ipamorelin in the same shot.
Always with a sports-medicine doctor, telehealth provider, or specialist sign-off. Self-experimenting on injection schedules without clinical input is the most common way people waste money and get hurt.
What to skip
- Vendors without a Certificate of Analysis (COA). Random gym-bro vendors with no third-party testing. The peptide market has a quality-control problem; the answer is COA per peptide, every time.
- Pre-mixed blends from non-pharmacy sources. Compounding pharmacies that produce pre-mixed combinations with COAs are fine. Random vendor "stack vials" are not.
- Massively over-dosed protocols. More is rarely better with peptides. Receptor saturation is real. Stick to evidence-based dosing.
Where to go next
- Full CJC-1295 directory entry - status, sourcing, studies, what to skip
- What are peptides - if you skipped the foundation
- How peptides actually work - mechanism in plain English
- The Tier List - which ones to take seriously
- Subscribe to the dispatch